Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR00364
|
|||||
| Drug Name |
Amanitin
|
|||||
| Synonyms |
alpha-amanitin
|
|||||
| Drug Type |
Small molecular drug
|
|||||
| Indication | Discovery agent [ICD11: N.A.] | Investigative | ||||
| Structure |
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C39H54N10O14S
|
|||||
| Canonical SMILES |
CCC(C)C1C(=O)NCC(=O)NC2CS(=O)C3=C(CC(C(=O)NCC(=O)N1)NC(=O)C(NC(=O)C4CC(CN4C(=O)C(NC2=O)CC(=O)N)O)C(C)C(CO)O)C5=C(N3)C=C(C=C5)O
|
|||||
| InChI |
InChI=1S/C39H54N10O14S/c1-4-16(2)31-36(60)42-11-29(55)43-25-15-64(63)38-21(20-6-5-18(51)7-22(20)46-38)9-23(33(57)41-12-30(56)47-31)44-37(61)32(17(3)27(53)14-50)48-35(59)26-8-19(52)13-49(26)39(62)24(10-28(40)54)45-34(25)58/h5-7,16-17,19,23-27,31-32,46,50-53H,4,8-15H2,1-3H3,(H2,40,54)(H,41,57)(H,42,60)(H,43,55)(H,44,61)(H,45,58)(H,47,56)(H,48,59)/t16?,17?,19?,23-,24-,25-,26-,27-,31-,32-,64?/m0/s1
|
|||||
| InChIKey |
CIORWBWIBBPXCG-JZTFPUPKSA-N
|
|||||
| Pharmaceutical Properties | Molecular Weight | 919 | Topological Polar Surface Area | 400 | ||
| Heavy Atom Count | 64 | Rotatable Bond Count | 7 | |||
| Hydrogen Bond Donor Count | 13 | Hydrogen Bond Acceptor Count | 15 | |||
| XLogP |
-4.4
|
|||||
| PubChem CID | ||||||
| PubChem SID | ||||||
| TTD Drug ID | ||||||
| DT(s) Transporting This Drug | OATP1B3 | Transporter Info | Organic anion transporting polypeptide 1B3 | Substrate | [1] | |
| Drug-Transporter Activity Data | ||||||
| Drug-Transporter Activity Data | OATP1B3 | Transporter Info | Km = 3.7 microM | Madin-Darby canine kidney cells (MDCKII)-OATP1B3 | [1] | |
| References | ||||||
| 1 | Molecular characterization and inhibition of amanitin uptake into human hepatocytes. Toxicol Sci. 2006 May;91(1):140-9. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.